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Abstract
Introduction: Building on earlier works demonstrating the effectiveness and acceptability of provider-initiated counselling and
testing (PITC) services in integrated outpatient departments of urban primary healthcare clinics (PHCs), this study seeks to
understand the relative utility of PITC services for identifying clients with early-stage HIV-related disease compared to traditional
voluntary testing and counselling (VCT) services. We additionally seek to determine whether there are any significant differences
in the clinical and demographic profile of PITC and VCT clients.
Methods: Routinely collected, de-identified data were collated from two cohorts of HIV-positive patients referred for HIV
treatment, either from PITC or VCT in seven urban-integrated PHCs. Univariate and multivariate analyses were conducted to
compare the two cohorts across demographic and clinical characteristics at enrolment.
Results: Forty-five per cent of clients diagnosed via PITC had CD4B200, and more than 70% (i.e. two thirds) had CD4B350 at
enrolment, with significantly lower CD4 counts than that of VCT clients (pB0.001). PITC clients were more likely to be male
(p0.0005) and less likely to have secondary or tertiary education (pB0.0001). Among those who were initiated on
antiretroviral therapy (ART), PITC clients had lower odds of initiating treatment within four weeks of enrolment into HIV care
(adjusted odds ratio, or AOR: 0.86; 95% confidence interval, or CI: 0.750.99; p0.035) and significantly lower odds of
retention in care at six months (AOR: 0.84; CI: 0.770.99; p0.004).
Conclusions: In Lusaka, Zambia, large numbers of individuals with late-stage HIV are being incidentally diagnosed in outpatient
settings. Our findings suggest that PITC in this setting does not facilitate more timely diagnosis and referral to care but rather act
as a ‘‘safety net’’ for individuals who are unwilling or unable to seek testing independently. Further work is needed to document
the way provision of clinic-based services can be strengthened and linked to community-based interventions and to address
socio-cultural norms and socio-economic status that underpin healthcare-seeking behaviour.
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Introduction
In sub-Saharan Africa (SSA), significant progress has been
made in the past decade in providing access to antiretroviral
therapy (ART) to persons living with HIV and diagnosed with
AIDS. By 2010, almost 40% of those in need of ART in SSA
were receiving care and treatment compared with just 2% in
2003. In addition, HIV-related deaths in SSA decreased
by 18% between 2004 and 2009 from 740,000 to 610,000
annually [1]. Notwithstanding these improvements, SSA still
has the world’s greatest burden of HIV and AIDS. In 2009, for
example, an estimated 22.5 million adults and children in the
region were living with HIV and an estimated 1.3 million (72%
of the global total) died from HIV-related diseases [2].
As the need for continued scale-up of effective HIV
treatment programmes meets the need to consolidate and
maintain the quality of existing programmes, policy makers
and health programmers are faced with two major on-going
challenges. First, the high proportion of individuals ignorant
of their HIV status. Second, the high proportion of HIV-
positive individuals diagnosed late and presenting for treat-
ment with advanced-stage HIV-related disease. Illustrating
these issues, it was estimated that in 2009 only 30% of adults
in SSA were aware of their disease status [2] and amongst
those who accessed treatment in 2009, between 8% and 26%
died during the first year of care [35].
Globally, strategies to reduce mortality, disease progres-
sion and transmission of HIV have included trialling the
provision of different models of testing to strengthen access
to testing, with generally positive outcomes [68]. Similarly,
the revision of World Health Organization’s (WHO) clinical
guidelines to recommend initiation of ART for all HIV-
positive individuals with a CD4B350 cells/mL regardless of
symptoms, and all tuberculosis (TB) patients regardless of
CD4 count [9,10], were designed to ensure more timely
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treatment. Such initiatives have been underscored by recent
evidence demonstrating that earlier initiation of ART (i.e.
initiation at a higher CD4 count) is associated with a 41%
relative reduction in HIV-related clinical events (primarily
extra-pulmonary TB) and a reduction of the incidence of HIV
transmission amongst discordant heterosexual couples by up
to 96% [11].
Because of the clinical and public health benefits of early
treatment initiation, it is imperative to provide evidence not
just of whether different models of testing increase access
to testing, but also whether such models facilitate earlier
diagnosis of HIV. While it is presumed that increased
access to HIV testing combined with guidelines that fast-
track treatment initiation will result in earlier treatment, this
assumption has rarely been tested [12].
Methods
Setting
In April 2004, a large-scale public sector HIV care and
treatment programme was established in Lusaka by the
Zambian Ministry of Health, with implementation assistance
from the Centre for Infectious Disease Research in Zambia
(CIDRZ) and funding from the President’s Emergency Plan for
AIDS Relief (PEPFAR). During initial scale up, HIV care and
treatment departments were established at the primary care
level, co-located but functionally separate from general
outpatient services. Clients could enrol free of charge for
treatment by presenting at any HIV care and treatment
department with a test result or referral slip from an
accredited HIV testing service. This included voluntary testing
and counselling (VCT) services that operated within the
primary care clinics themselves.
By 2008, 22 of Lusaka’s 27 primary healthcare clinics (PHCs)
had a co-located and stand-alone HIV care and treatment
department. In the same year, partially as a response to
concerns over siloed HIV service delivery, duplication of effort
and treatment-related stigma, a model of integrated HIV and
general outpatient healthcare services was piloted in two
Lusaka clinics [7]. Under the integrated model, formerly
stand-alone HIV care and treatment departments and general
outpatient departments were integrated. All patients, regard-
less of HIV status, presented to the same clinic and were
attended by the same staff. Patient flow, healthcare worker
duties, medical record filing and pharmaceutical dispensing
and storage were harmonized [7]. In addition, following WHO
and Centers for Disease Control and Prevention (CDC)
recommendations [13,14], the integrated departments intro-
duced first-come first-serve provider-initiated counselling and
testing (PITC) for any client without a recent (B6 months) HIV
test result [15].
Newly introduced PITC services in the integrated clinics
differed from the pre-existing VCT services in several key
ways. Typically, clinic-based VCT services were staffed by
nurses whose primary responsibility lay elsewhere but they
provided VCT in a spare room during their free time. As a
result, the service was only available on an ad hoc basis. The
majority of VCT clients were self-initiated and counselling in
VCT was conducted according to psycho-social principles
without reference to clients’ clinical condition. If a client
tested positive to HIV in VCT, he or she was issued with a
referral slip and required to (self) present to the separate
HIV care and treatment department for enrolment. Human
resource shortages meant that when patients received
a referral they were rarely, if ever, accompanied by a
healthcare worker.
By contrast, PITC established in the newly integrated clinics
was offered routinely on an ‘‘opt-out’’ basis to all clients
attending the out-patient department (OPD) who had no
knowledge of their HIV status. PITC was physically located
within the OPD and formed part of a standardized patient
flow, requiring no separate or additional queuing. Those who
tested positive to HIV were able to enrol in HIV care and
treatment department immediately or later and did so in the
same building as all other outpatient services. Since PITC was
offered by (trained and supervised) lay personnel who
worked five-hour shifts from Monday to Friday [15], clients
attending the clinic outside those hours or during particularly
busy periods may not have been tested. However, if a client
had an accompanying child, spouse or other adult, all present
were offered (private) counselling and testing. Further details
related to the programmatic features, including implementa-
tion, supervision and subsequent scale-up, have been
previously published [7,15,16].
Both the integrated model as a whole and the incorpora-
tion of PITC specifically were designed to improve access to
HIV testing and more timely referral for care and treatment.
Since VCT services relied primarily on client self-referral (both
to the testing services itself and subsequently to HIV care and
treatment), it was anticipated that PITC would improve
linkages to HIV care through provision of fully integrated,
seamless service delivery [14,1618]. Between 2009 and
2011, a further seven clinics (nine in total) were integrated
and PITC was introduced. In 2011, the programmatic out-
comes were published, including evidence of improved
testing coverage, and high levels of acceptability [15].
However, initial work did not examine the clinical and
demographic profile of those accessing PITC or address the
question of whether PITC in fact facilitated earlier diagnosis
and initiation of treatment.
Objective
Building on earlier works, this study describes results from a
cross-sectional study of a cohort of HIV-positive patients
referred for ART in seven urban-integrated primary care
clinics, via the recently established PITC services and pre-
existing VCT services. The study aimed to a) understand the
relative utility of PITC services for identifying clients with
early-stage HIV-related disease compared to VCT services
(using CD4 count as a proxy for disease stage) and b)
determine whether there are any significant differences in
the clinical and demographic characteristics of clients acces-
sing PITC and VCT with regard to implications for scaling-up
different types of testing models in the future.
Site selection
Sites for this study were chosen purposively from a total
sample of 13, based on at least six months of integrated
status of their HIV care and treatment programme, the
presence of PITC services and the presence of onsite data
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entry of ART medical records into the national electronic
medical database (SmartCare). Basic characteristics of each
facility are reported in Table 1.
Data collection
Programmatic data from the national HIV care and treatment
programme in Lusaka were analyzed. This programme is
supported primarily by the Ministry of Health, with additional
funding from the PEPFAR and the Global Fund for AIDS,
Tuberculosis and Malaria (GFATM). Clinical care has been
standardized according to national protocols. Clinical and
demographic data are recorded on standardized forms by
healthcare workers and subsequently entered into an
electronic database (SmartCare) by dedicated, on-site data
entry clerks.
Data relevant to this study included the number of
patients counselled, tested and identified as HIV-positive in
PITC services in the seven clinics between July 2008 and June
2011. Data were collated monthly from clinic registers,
entered manually into an electronic database and cleaned
by a project coordinator from the CIDRZ. A cohort of PITC
clients who had enrolled for HIV care was subsequently
identified by cross-referencing the unique patient identifiers
of HIV-positive PITC clients with the national electronic
medical database, SmartCare. The cohort included all those
who were matched in SmartCare for the period from the
start of integrated service delivery for each clinic up to our
study freeze date (1 July 2011). Likewise, the VCT cohort of
clients was extracted from the SmartCare database, based on
two criteria: i) having enrolled in HIV care in any of the seven
clinics during the same period of integrated service delivery
and ii) documented as having being referred by any VCT
service. Because of unlinked patient identification numbers
in VCT, data on the rates of counselling, testing and
successful referral to care were not available for the VCT
cohort [15].
Analysis
De-identified demographic and clinical characteristics at
enrolment, including age, CD4 cell count (cells/mL), body
mass index (BMI; kg/m2), haemoglobin (Hgb; g/dL) levels, as
well as education level, and partner’s HIV status, were
extracted from SmartCare for both cohorts. We investigated
five programmatic outcomes: (i) ever initiated ART, if eligible;
ii) initiated ART within four weeks of HIV care; iii) retention in
HIV care at six months; iv) early mortality (within 90 days of
enrolment); and v) medication possession ratio (MPR) at
six months post-ART initiation. According to the Zambian
national guidelines, during the period of analysis, patients
were defined as eligible for ART if they were documented as
having CD4 countB200 cells/mL or WHO Stage III or IV
disease. For retention in care, only patients with a minimum
of six months between their HIV care enrolment date and the
study freeze date were evaluated. Retention at six months
was defined as having a pharmacy or clinical visit date within
a 60-day window in six months’ time, post-enrolment date
[19]. For patients initiated on ART at least six months prior to
the study freeze date, MPR at six months was calculated by
dividing the number of days beyond designated pharmacy
refills by total days on therapy and then subtracting that
percentage from 100. Patients were classified as optimally
adherent (]95%), sub-optimally adherent (8094%) or
poorly adherent (B80%) [20].
We used Pearson’s Chi-square test for categorical variables
and non-parametric Wilcoxon rank-sum tests for continuous
variables to compare demographic and clinical characteristics
between PITC and VCT patients. Crude odds ratios (ORs) and
95% confidence intervals (95% CIs) were computed using
logistic regression models to assess the relationship between
testing group and the five programmatic outcomes. AORs
and their corresponding 95% CIs were generated using
generalized estimating equations to account for clustering
by site. Age, sex, CD4 cell count, BMI, HGB, TB status at
enrolment, education level and partner HIV status were
included in the multivariate models.
Analyses were performed using SAS Version 9.1 (Cary, North
Carolina), and the protocol was approved by the institutional
review boards of the University of Zambia, Protocol # 003-02-
08 (Lusaka, Zambia), and the University of Alabama at
Birmingham, Protocol # X080403013 (Birmingham, Alabama,
USA), and received clearance from the Zambian Ministry
of Health.
Table 1. Clinic characteristics of nine integrated urban primary health care facilities
Integrated
Clinics
ART Introduced
to clinic
ART Integrated
in clinic
Catchment
population (2010)
Approx. daily
outpatient attendance
Ever enrolled
(b/f 1 July 2011)*
PITC**
cohort
VCT**
cohort
Clinic 1 Jan 2005 Nov 2008 52,549 100 3,822 337 1014
Clinic 2 Feb 2009 Feb 2009 18,050 45 1,907 263 1364
Clinic 3 Aug 2004 Apr 2010 74,116 180 13,032 92 1,339
Clinic 4 May 2008 Oct 2009 47,904 95 3,987 489 1,370
Clinic 5 Mar 2007 Jun 2010 28,979 60 4,896 51 1,038
Clinic 6 Jul 2006 Apr 2009 70,219 120 7,057 546 1,928
Clinic 7 Mar 2007 Jul 2008 31,872 80 3,802 461 1,677
TOTAL   323,689 680 38,503 2239 9730
* Includes clients referred from TB Department and Maternal & Child Health Department; b/fbefore.
** VCT and PITC cohort numbers represent those enrolled from the date of integration at each clinic through to 1 July 2011. Only clients
newly enrolled from the date that ART was integrated in each clinic were included; clients enrolled before this date are automatically excluded.
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Results
Between July 2008 and January 2011, 2239 clients were
matched with our enrolment records after testing HIV-
positive in PITC. A comparison cohort of 9730 clients enrolled
via VCT at the same clinics during the same period (Table 2).
The larger number of client enrolments via VCT during this
period is primarily due to a larger number of VCT referral
services. These include VCT services at each of the integrated
clinics, VCT services at other government clinics and stand-
alone private and non-profit testing services, all of which may
refer HIV-positive clients to public HIV care and treatment
services. In addition, VCT services were operating prior to the
period of analysis, with the possibility of clients who tested
positive any time in the past presenting at the clinics for
enrolment during the period of analysis. By comparison,
the PITC cohort could include only those who tested in the
Table 2. Baseline demographic and clinical characteristics for clients accessing HIV treatment in nine integrated clinics via PITC
and VCT
Characteristics PITC* median (IQR) or N (%) VCT** median (IQR) or N (%) p
Age N2239 N9730
At enrolment 32.0 (26.039.0) 32.0 (26.038.0) 0.5429^
515 225 (10.0%) 719 (7.4%) B0.0001^^
1635 1193 (53.3%) 5617 (57.7%) .
36 821 (36.7%) 3394 (34.9%) .
Sex N2239 N9730
Female 1261 (56.3%) 5868 (60.0%) 0.0005^^
Male 978 (43.7%) 3862 (40.0%) .
N1998 N8506
CD4 (cells/mL) at enrolment 224 (110.0387.0) 264 (137.0427.0) B0.0001^
550 223 (11.2%) 701 (8.3%) B0.0001^^
51199 676 (33.8%) 2561 (30.1%) .
200349 514 (25.7%) 2195 (25.8%) .
]350 585 (29.3%) 3049 (35.8%) .
N1932 N8602
BMI (kg/m2) at enrolment 20.0 (18.122.2) 20.4 (18.422.8) B0.0001^
B18.5 559 (28.9%) 2196 (25.5%) B0.001^^
18.524.99 1180 (61.1%) 5357 (62.3%) .
]25 193 (10.0%) 1049 (12.2%) .
N1951 N8339
HBG (g/dL) at enrolment 11.2 (9.712.6) 11.7 (10.113.2) B0.0001^
58 163 (8.4%) 539 (6.5%) B0.0001^^
8.19.9 388 (19.9%) 1420 (17.0%) .
]10 1400 (71.8%) 6380 (76.5%) .
Active TB at enrolment N2239 N9730
Yes 113 (5.0%) 99 (1.0%) B0.0001^^
No 2126 (95.0%) 9631 (99.0%) .
Education N2234 N9092
None 809 (36.2%) 2503 (27.5%) B0.0001^^
Primary 674 (30.2%) 2919 (32.1%) .
Secondary and tertiary 751 (33.6%) 3670 (40.4%) .
Partner HIV status N2239 N9730
Negative 93 (4.2%) 500 (5.1%) B0.0001^^
Positive 376 (16.8%) 2611 (26.8%) .
Unknown/missing 1770 (79.1%) 6619 (68.0%) .
*PITCClients who tested positive to HIV in provider-initiated testing services available in an integrated clinic and subsequently enrolled in HIV
care up to study cut-off date.
**VCTClients who tested positive to HIV in any (on-site or off-site) voluntary HIV testing services and enrolled in HIV care in an integrated
clinic, up to study cut-off date.
^ Wilcoxon rank-sum tests.
^^ Pearson’s Chi-square test.
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outpatient departments of the nine integrated clinics follow-
ing the introduction of PITC (maximum of 24 months).
Clinical and demographic characteristics
In the PITC cohort, the median age was 32 years, median
CD4224 cells/mL and median BMI20.0 (Table 2). Chil-
dren (under 15 years) constituted 10% (n225) of the
cohort and males made up 43.7%. Approximately 45% of the
PITC cohort had a CD4 5200 cells/mL, whereas 70% had a
CD4 5350. Just under a third of the cohort (29%) had BMI
below the normal range (B18.0). In the same cohort, 36%
were reported as having no formal education, 30% as having
some primary education and 34% as having some secondary
or tertiary education. The majority (79%) of PITC clients
either did not know or did not report their partner’s HIV
status and 5% had active TB at the time of enrolment into
HIV care. Disaggregating the PITC cohort by gender, men had
more advanced HIV-related disease than women as evi-
denced by lower median CD4 cell counts (268 vs. 302 cells/
mL; p0.004) and lower median BMI (19.5 vs. 21.3 kg/m2;
pB0.0001).
In the VCT cohort, the median age was 32 years, median
CD4264 cells/mL and median BMI20.4 (Table 2).
Children under 15 years constituted 7.4% of the cohort and
males made up 39.7%. Approximately 38% of the VCT cohort
had a CD4 5200 cells/mL, whereas 64% had a CD4 5350
cells/mL, and just under a third (28.9%) had BMI below
the normal range (B18.5). In the same cohort, 25.7% were
reported as having no formal education, 30% as having some
primary education and 37.7% as having some secondary or
tertiary education. Some 68% of VCT clients either did
not know, or did not report their partner’s HIV status
and 1% (n99) had active TB at the time of enrolment
into HIV care.
By comparison to the VCT cohort, more PITC clients were
men (43.7% vs. 39.7%, pB0.0005). Age distribution also
differed significantly (pB0.0001) with the PITC cohort having
more children under 15 years (10% vs. 7.4%) and more adults
over 35 years (36.7% v. 34.9%), but fewer adults in the high-
risk age group of 1635 (53.3% vs. 57.7%). Median baseline
CD4 for PITC patients was 224 cells/mL versus 264 cells/mL in
the VCT cohort (pB0.0001). At enrolment, more PITC clients
were underweight (BMIB18.5) (28.9% vs. 25.5%; pB0.0001)
and had low HGB (58 g/dL) (8.4% vs. 6.5%; pB0.0001) by
comparison to the VCTcohort. The PITC cohort was also found
to have significantly more active TB at enrolment (5.0% vs.
1.0%; pB0.0001).
Differences were also identified in the educational status
and knowledge of partners’ HIV status (Tables 2 and 3). PITC
clients were more likely to be uneducated (36.2% vs. 27.5%)
and less likely to have a primary (30.2% vs. 42.1%) or
secondary (33.6% vs. 40.4%) education (pB0.0001). Simi-
larly, fewer PITC clients were able report their partner’s HIV
status (21.0% vs. 31.9%; pB0.0001). Amongst both PITC and
VCT clients, a greater proportion of men compared to women
had primary and/or secondary education and also knew their
partner’s HIV status (Table 3). More men than women had
active TB at enrolment in the PITC cohort, whereas in the VCT
cohort, TB at enrolment was found in equal proportions
among men and women.
Programmatic outcomes
Table 4 reports the results of five analyses, exploring the
association between testing group and five programmatic
outcomes. Multivariate analyses are adjusted for age, sex,
enrolment CD4 cell count, BMI, HGB and TB status. Adjusted
analysis showed a marginal association between the testing
cohort and the outcome ‘‘Dead in 90 Days’’ (AOR: 1.36;
CI: 0.941.96; p0.10). The odds of being ‘‘Initiated on ART
if eligible’’ were lower for PITC patients than for VCT patients
(AOR: 0.9; 95% CI: 0.820.97; p0.01). Among those who
initiated ART, PITC patients had lower odds of initiating
within four weeks’ of enrolment for HIV care (AOR: 0.86; 95%
CI: 0.750.99; p0.035). PITC clients also had reduced odds
of being retained in care at six months (AOR: 0.84; 95% CI
0.740.95; p0.004). No difference was found in the MPR
between the two cohorts (p0.982).
Discussion
Clinical outcomes
Previous work has demonstrated that access to, and uptake
of, HIV testing in Lusaka can be strengthened by incorporat-
ing routine PITC into integrated primary care services [15].
Until now, the critical question of whether or not such
Table 3. Education level, partner serostatus and active TB
among male and female PITC and VCT Clients
Sex Education status *PITC (%) **VCT (%) p^
Male No education 330 (34%) 922 (26%) B0.0001
Primary 268 (27%) 977 (27%)
Secondary 378 (39%) 1701 (47%)
Female No education 479 (38%) 1581 (29%) B0.0001
Primary 406 (32%) 1942 (35%)
Secondary 373 (30%) 1969 (36%)
Partner HIV status PITC (%) VCT (%)
Male Negative 61 (6%) 284 (7%) B0.0001
Positive 203 (21%) 1293 (33%)
Unknown or missing 714 (73%) 2285 (59%)
Female Negative 32 (3%) 216 (4%) B0.0001
Positive 173 (14%) 1318 (22%)
Unknown or missing 1056 (84%) 4334 (74%)
Active TB at enrolment PITC (%) VCT (%)
Male No TB 914 (93%) 3821 (99%) B0.0001
Active TB 64 (7%) 41 (1%)
Female No TB 1212 (96%) 5810 (99%) B0.0001
Active TB 49 (4%) 58 (1%)
*PITCClients who tested positive to HIV in provider-initiated
testing services available in an integrated clinic and subsequently
enrolled in HIV care up to study cut-off date.
**VCTClients who tested positive to HIV in any (on-site or off-site)
voluntary HIV testing services and enrolled in HIV care in an
integrated clinic, up to study cut-off date.
^ Pearson’s Chi-square test.
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routine PITC improves the timeliness of that HIV treatment
has remained unanswered. In this large urban cohort, we
found 45% of HIV-positive clients diagnosed via PITC had
CD4B200 cells/mL, and more than two-thirds (70%) had
CD4B350 cells/mL at enrolment. Compared to clients
enrolled from VCT, PITC clients had significantly higher rates
of late-stage disease and active TB at enrolment. Our results
demonstrate that majority of clients accessing HIV care via
PITC services have advanced immune-suppression, resulting
in less timely treatment according to current WHO and
Zambian national standards.
Delayed diagnosis of HIV and later initiation on ART is
associated with poor clinical outcomes. Recent studies
demonstrate that initiating ART at CD4 levels higher than
200 or 250 cells/mL reduces mortality rates in asymptomatic,
ART-naive, HIV-positive people [21]. Sterne and colleagues
found that deferring combination therapy until CD4251
350 cells/mL was associated with higher rates of AIDS and
mortality than starting therapy in the range 351450 cells/mL
(HR: 1.28, 95% CI 1.041.57), and that the adverse effect of
deferring treatment increased with decreasing CD4 cell count
threshold [22]. Delayed initiation on ART also has implica-
tions for population health, with the HIV Prevention Trials
Network (HPTN) 052 trial [11] demonstrating a 96% relative
reduction in HIV transmission between sero-discordant
couples who initiated ART earlier (CD4 350550 cells/mL).
Programmatic outcomes
The PITC and VCT cohorts received care contemporaneously
and within the same facilities. Despite this, we found that in
comparison to VCT clients, PITC clients had reduced odds of
being initiated on ART within four weeks (of being identified
as eligible) and significantly higher rates of loss-to-follow-up
(LTFU), especially during the first 180 days of enrolment in
HIV care and treatment. Higher rates of LTFU in the PITC
cohort may be partially explained by higher rates of
unrecorded mortality. Evidence from previous modelling
studies suggests that unrecorded deaths may be responsible
for up to 30% of early LTFU [23], and PITC clients in this
cohort had significantly higher risk of being severely immuno-
suppressed by comparison to VCT clients. Another contribut-
ing factor could be that PITC clients with active TB refused,
were advised against or defaulted from HIV care
and treatment while still on anti-TB therapy due to fear
or misconceptions regarding TB/HIV co-treatment [24].
Table 4. Outcomes for PITC and VCT clients across four clinical management indicators
Programmatic outcomes1 Number of clients Crude odds ratio7 p Adjusted odds ratio8 p
Dead in 90 days2
VCT3 155/8680 (1.8%) Referent Referent
PITC4 75/2239 (3.3%) 1.91 (1.442.52) B.001 1.36 (0.941.96) 0.100
Initiated on ART if eligible5
VCT 4523/6520 (69.4%) Referent Referent
PITC 1187/1655 (71.7%) 1.12 (0.991.26) 0.063 0.90 (0.820.97) 0.010
Time to ART initiationB4 weeks (among those who initiated)
VCT 2828/4523 (62.5%) Referent Referent
PITC 665/1187 (56.0%) 0.76 (0.670.87) B.001 0.86 (0.750.99) 0.035
Retained in care at 6 months
VCT 3765/6079 (61.9%) Referent Referent
PITC 1105/1929 (57.3%) 0.82 (0.740.91) B.001 0.84 (0.740.95) 0.004
MPR6 95 after 6 months on ART
VCT 1604/2880 (55.7%) Referent Referent
PITC 543/933 (58.2%) 1.11 (0.951.29) 0.180 1.00 (0.791.27) 0.982
1 Denominator for those included in programmatic outcome includes those with sufficient follow-up time and those with data available in the
electronic medical record. For example, MPRB95 after six months on ART was assessed amongst those initiated on ART for at least six months
within the time parameters. Additionally, since the study relied on routinely collected data some clients had missing data excluding them from
analysis.
2 Dead in 90 Daysclients recorded as dead within 90 days of enrolling in HIV care and treatment.
3 VCTClients who tested positive to HIV in any (on-site or off-site) voluntary HIV testing services and enrolled in HIV care in an integrated
clinic, up to study cut-off date.
4 PITCClients who tested positive to HIV in provider-initiated testing services available in an integrated clinic and subsequently enrolled in HIV
care up to study cut-off date.
5 Initiated on ART if eligibleclients enrolled in HIV care and treatment and initiated on antiretroviral therapy if eligible according to Zambian
national guidelines.
6 MPRMedication possession ratio, an estimation of client adherence to individual antiretroviral drug regime.
7 Crude odds ratios (ORs) and 95% confidence intervals (95% CIs) computed using logistic regression models to assess the relationship between
testing group and the five programmatic outcomes.
8 Adjusted odds ratios (AORs) and their corresponding 95% CIs generated using generalized estimating equations to account for clustering by
site; adjusted for age, sex, CD4 cell count, BMI, HGB, TB status at enrolment, education level and partner HIV status.
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PITC patients may also be less psychologically prepared for
HIV care and treatment contributing to a higher rate of LTFU.
Gender and socio-economic indicators
Social determinants are well recognized to affect health status
and healthcare-seeking behaviour [25], and our analysis
suggests that late presentation for testing and LTFU amongst
HIV-positive clients in this setting is no exception. After
comparing a number of socio-demographic characteristics, we
found HIV-positive clients enrolled via PITC were significantly
more likely to be male, illiterate, unaware of their partner’s
HIV status, and children aged under 15 years.
A lower level of education impedes both understanding
of, and access to, information about HIV and the treatment
options available. Clients with less education may thus be
less informed or ill-informed about the nature of HIV and HIV
treatment. Lower educational attainment is also associated
with a less empowered population, who may be susceptible
to myths and misconceptions and less confident to seek
outside care and support until late in their disease progres-
sion when all other options have been exhausted. This
explanation meshes with an outpatient population that
receives HIV testing co-incidentally (as part of a routine
opt-out service) after presenting sick to a general outpatient
department. Such clients may similarly be more susceptible
to abandoning ART, where clinical improvement or ‘‘feeling-
well’’ is (mis-)interpreted as being ‘‘cured’’.
Although the PITC cohort had proportionally more adult
males and children compared to VCT, women constituted the
majority. Critically, our findings demonstrated that women in
the PITC cohort were less educated and more immuno-
suppressed compared to both men in the same PITC cohort
and women in the VCT cohort. Gender norms that subjugate
women and girls in Zambia both influence and are influenced
by low educational status and women and girls’ social and
financial dependence on fathers, brothers and husbands [26].
In a setting where HIV-positive individuals risk discrimination,
abandonment and dispossession, women are less likely to
prioritize their health [27]. These findings potentially reflect
the nexus of gender and socio-cultural norms and economic
dependence that make seeking HIV testing and treatment
(particularly during the early non-symptomatic disease stages)
a lower priority for women compared to issues of financial
security and social acceptance.
Children under 15 years represented a significantly larger
proportion of the PITC versus VCT cohort. As with women,
children in Zambia are less likely to be empowered to make a
decision to actively seek HIV testing and treatment, typically
relying on parents or older family members to help them.
Parents, particularly mothers, may actively avoid testing their
children, with previous work in the region documenting a
variety of reasons, including the perceived futility of knowing
a child’s status [2830], poor caregiver knowledge of
paediatric HIV infection and available healthcare services
[31], a fear of spousal abandonment when a mother’s HIV-
positive status is inferred from her child’s [32] and fear of
children’s negative reactions and of inability to answer their
questions [3335].
Compared to VCT, there were a significantly higher
proportion of men in the PITC cohort. Several factors may
have contributed to this. In SSA, cultural norms and stigma
proscribe seeking medical care other than for acute illnesses
[3641], a critical factor in relation to HIV, which can fre-
quently be asymptomatic until its advanced stages. Similarly,
men in SSA are less likely to seek healthcare voluntarily,
especially where it involves long waiting times that clash with
formal or informal employment [25,40,4245]. Due in part to
the association of PHCs with maternal and child health, these
facilities are commonly perceived to be a ‘‘female’’ domain,
potentially contributing to a reticence by men to indepen-
dently seek out services. Men may also be less likely to
perceive themselves as ‘‘at risk’’ of being HIV positive [46].
Such factors may lead men to present for outpatient care
only when they are symptomatic, rather than specifically
testing for HIV. Further supporting this hypothesis is the
finding that men in the PITC cohort had proportionally more
active TB than any other group.
Alternative models
In view of the clinical capacity to reduce mortality and
disease progression and prevent HIV transmission through
earlier care and treatment, greater attention must be paid to
ways to improve timely diagnosis and subsequent care.
Although PITC has been shown to improve access to testing
and provide an additional route to HIV care and treatment
in many settings including Zambia, the findings presented
here suggest that, in Zambia, these services by themselves
are insufficient to improve the timeliness of that care.
Improving clinic-based services, including a reduction in
clinic waiting times, more intensive pre- and post-test HIV
counselling and adherence support for those initiating ART,
presents a starting point. For these services, an increasingly
strong evidence-base is emerging regarding the critical role
played by clinic-based lay counsellors and peer educators.
However, moving beyond the clinic, home-based HIV coun-
selling and testing (HBHCT) and home-based care (HBC),
particularly those models supported by community health
workers providing door-to-door services to consenting com-
munity members [12], present a strong alternative. HBHCT
has been shown to increase uptake of HIV testing, improve
access to testing, as well as limiting travel costs and reducing
the likelihood of stigma [8,12,13]. Evidence from Kenya and
Uganda demonstrates that HBC for people living with HIV and
AIDS can produce equally good clinical outcomes as com-
pared to clinic-based care, at a lesser cost to both clients and
providers [47,48]. Unfortunately, HBHCT and HBC models
tested to date have had limited coverage and there is
insufficient evidence linking such services to more timely
testing and treatment on a larger scale [49,50].
Ultimately, further work is needed to document the
possibilities inherent in more holistic community-based
interventions that are better able to account for the
way cultural taboos, gender inequity, educational status
and economic dependence shape health-related decision
making.
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Limitations
Despite this study including a large number of HIV-positive
patients, it may not be representative of Zambians at-large
as the patients were drawn from an urban population. The
study relied on routinely collected data, making it susceptible
to the limitations of operational research, including missing
data that may have skewed results. Importantly, the database
used was not primarily designed to assess access to testing or
delayed diagnosis and results should therefore be interpreted
with caution. The scope of this study, which focuses on
clients’ clinical and demographic characteristics and uses
routinely collected data, did not allow us to collect detailed
information on clinic-based factors, such as staffing or
other supply-side factors that may have influenced client
behaviour. Finally, whether accessing HIV or general clinic
services, PITC and VCT clients are by definition self-selecting.
Those who access PITC via primary healthcare outpatient
departments were likely to be more ill as they were
presumably seeking medical care; however, we cannot
eliminate the possibility of some clients presenting in the
outpatient departments to receive testing. In addition, our
programmatic data did not allow us to distinguish between
VCT clients referred from services located on PHC premises
versus those located external to the clinic (e.g. NGO-run).
Further and more rigorous work in this area is required to
answer important questions, including whether community-
based testing and treatment models (already known to
improve access) also improve the rates of early diagnosis
and facilitate retention in care in high-prevalence settings,
and how established clinic-based services can better address
the socio-cultural barriers to testing and care-seeking that
continue to inhibit uptake of care and retention in clinic-
based care and treatment.
Conclusions
Our findings indicate that large numbers of HIV-positive
individuals with late-stage disease (particularly those with
less education) are being ‘‘incidentally’’ identified in out-
patient settings. Contrary to expectation then, PITC in this
high-prevalence setting does not appear to be facilitating
more timely diagnosis and referral to care. Rather, in Lusaka,
Zambia, PITC is acting as a ‘‘safety net’’ for individuals who
are unwilling or unable to voluntarily seek testing. Although
PITC services are designed, in part, to facilitate linkage to care
for those who may not independently seek HIV testing or
treatment, it remains a concern that in a setting with such a
relatively mature HIV treatment programme, so many with
such late-stage disease are being incidentally identified. Our
results constitute further evidence that care-seeking beha-
viours in Zambia, as elsewhere, are influenced by a range of
social determinants that must be concurrently addressed to
improve timely uptake and retention in essential clinical
services.
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